RP Cure Tracker

Trials / NCT00001347

Study of Usher Syndromes, Type 1 and Type 2

Completed Observational Natural history / observational

Sponsor
National Eye Institute (NEI)
Treatment
Not listed
Gene
Not stated
Conditions
Retinitis Pigmentosa
Ages
Any to no upper limit
Enrollment
200 participants
Started
1993-06
Main results expected
Not stated
Results posted
Not yet
Record last updated
2008-03-04

What the study is testing

The purpose of this investigation is to gain additional knowledge about what causes type 1 and type 2 Usher syndrome-inherited diseases that can cause balance problems and impaired hearing and vision-and to develop better diagnostic tests. Patients with type 1 Usher syndrome usually are deaf from birth and have speech and balance problems. Patients with type 2 disease generally are hearing impaired but have no balance problems. All patients develop eye problems that cause difficulty seeing in the dark.

The development of newer and more sophisticated diagnostic tests may detect subtle differences in signs and symptoms that allow more accurate distinction between the two types of Usher syndrome. This study will use these tests to classify these syndromes and eventually identify the genes responsible for them.

Study participants will have a medical and family history taken and a family tree constructed. They will undergo a thorough eye examination, including special tests of color vision, field of vision, and ability to see in the dark. An electroretinogram will be done to measure the function of cells in the retina, and a procedure called fluorescein angiography will be done to look at and photograph the blood vessels in the retina. Special hearing and balance tests will also done. Hearing tests include physical examination of the ears and wearing earphones while listening to tones. Balance and coordination tests require tasks such as walking in a straight line and standing in the dark with eyes closed. A caloric stimulation test will also be done, in which a small amount of water is irrigated into the ear canal. For gene studies, blood samples will be collected from patients and all available family members.

Where it runs

United States (1)

Open on ClinicalTrials.gov for contacts and eligibility